Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Melatonin influences antioxidant homeostasis and basal metabolism in the BALB/c mouse model

M. Pohanka, H. Bandouchova, J. Pikula,

. 2012 ; 33 Suppl 3 () : 183-9.

Language English Country Sweden

Document type Journal Article, Research Support, Non-U.S. Gov't

OBJECTIVES: Melatonin is a hormone with strong antioxidant activity. It is biosynthesized in the pineal gland and serves in the biological signaling and control of the circadian rhythm. Though there is evidence of beneficial effects of melatonin, the substance was not investigated in greater details associated with specific regulation of oxidative stress in organs and tissues. DESIGN: The experiment is based on exposure of BALB/c mice to doses from 10 µg to 1mg of melatonin. Mice were euthanized after one and 24 hours, respectively. Biochemical markers in plasma, ferric reducing antioxidant power (FRAP), thiobarbituric acid reactive substances (TBARS) and activity of caspase-3 were examined in selected organs. RESULTS: We confirmed significant alteration in high-density lipoprotein and total cholesterols and glucose. After one day, levels of glucose and high-density lipoprotein cholesterol were decreased, while total cholesterol increased in a dose dependent manner. FRAP values increased in spleen, liver, kidney, heart, and brain indicating a growing potential of low molecular weight antioxidants 24 hours after exposure. However, TBARS values indicating oxidative stress were elevated in heart, kidney, and liver. CONCLUSIONS: Despite the antioxidant properties of melatonin, its effect on the organism is more complicated. It influences not only the oxidative homeostasis but also the basal metabolism, as represented by, e.g., cholesterol and glucose. This substance could thus be used for therapeutical purposes such as amelioration of pathologies associated with generation of reactive species or some metabolic dysfunctions.

000      
00000naa a2200000 a 4500
001      
bmc13023982
003      
CZ-PrNML
005      
20131002123230.0
007      
ta
008      
130703s2012 sw f 000 0|eng||
009      
AR
035    __
$a (PubMed)23353865
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Pohanka, Miroslav $u Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic. miroslav.pohanka@gmail.com
245    10
$a Melatonin influences antioxidant homeostasis and basal metabolism in the BALB/c mouse model / $c M. Pohanka, H. Bandouchova, J. Pikula,
520    9_
$a OBJECTIVES: Melatonin is a hormone with strong antioxidant activity. It is biosynthesized in the pineal gland and serves in the biological signaling and control of the circadian rhythm. Though there is evidence of beneficial effects of melatonin, the substance was not investigated in greater details associated with specific regulation of oxidative stress in organs and tissues. DESIGN: The experiment is based on exposure of BALB/c mice to doses from 10 µg to 1mg of melatonin. Mice were euthanized after one and 24 hours, respectively. Biochemical markers in plasma, ferric reducing antioxidant power (FRAP), thiobarbituric acid reactive substances (TBARS) and activity of caspase-3 were examined in selected organs. RESULTS: We confirmed significant alteration in high-density lipoprotein and total cholesterols and glucose. After one day, levels of glucose and high-density lipoprotein cholesterol were decreased, while total cholesterol increased in a dose dependent manner. FRAP values increased in spleen, liver, kidney, heart, and brain indicating a growing potential of low molecular weight antioxidants 24 hours after exposure. However, TBARS values indicating oxidative stress were elevated in heart, kidney, and liver. CONCLUSIONS: Despite the antioxidant properties of melatonin, its effect on the organism is more complicated. It influences not only the oxidative homeostasis but also the basal metabolism, as represented by, e.g., cholesterol and glucose. This substance could thus be used for therapeutical purposes such as amelioration of pathologies associated with generation of reactive species or some metabolic dysfunctions.
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x metabolismus $x toxicita $7 D000975
650    _2
$a bazální metabolismus $x účinky léků $x fyziologie $7 D001481
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a kaspasy $x metabolismus $7 D020169
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a homeostáza $x účinky léků $x fyziologie $7 D006706
650    _2
$a melatonin $x metabolismus $x toxicita $7 D008550
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a modely u zvířat $7 D023421
650    _2
$a oxidační stres $x účinky léků $x fyziologie $7 D018384
650    _2
$a látky reagující s kyselinou thiobarbiturovou $x metabolismus $7 D017392
650    _2
$a testy toxicity $7 D018675
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bandouchova, Hana $u -
700    1_
$a Pikula, Jiri $u -
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 33 Suppl 3(2012), s. 183-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23353865 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20131002123747 $b ABA008
999    __
$a ok $b bmc $g 987662 $s 822362
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 33 Suppl 3 $d 183-9 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20130703

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...